Google Akademik

Makaleler

Akademik

Yaklaşık 568 sonuç bulundu (0,02 sn)

The current coronavirus disease-2019 (COVID-19) pandemic is due to the novel coronavirus
SARS-CoV-2. The scientific community has mounted a strong response by accelerating …

Kaydet Alıntı yap Alıntılanma sayısı: 606 İlgili makaleler 15 sürümün hepsi Önbellek

[Free GPT-4]
[DeepSeek]

[PDF] nature.com

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

TP Sheahan, AC Sims, SR Leist, A Schäfer… - Nature …, 2020 - nature.com

Middle East respiratory syndrome coronavirus (MERS-CoV) is the causative agent of a
severe respiratory disease associated with more than 2468 human infections and over 851 …

Kaydet Alıntı yap Alıntılanma sayısı: 2235 İlgili makaleler 19 sürümün hepsi

[Free GPT-4]
[DeepSeek]

[PDF] asm.org

Remdesivir against COVID-19 and other viral diseases

JJ Malin, I Suárez, V Priesner… - Clinical microbiology …, 2020 - Am Soc Microbiol

Patients and physicians worldwide are facing tremendous health care hazards that are
caused by the ongoing severe acute respiratory distress syndrome coronavirus 2 (SARS …

Kaydet Alıntı yap Alıntılanma sayısı: 320 İlgili makaleler 10 sürümün hepsi

[Free GPT-4]
[DeepSeek]

[PDF] jbc.org Full View

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

CJ Gordon, EP Tchesnokov, E Woolner… - Journal of Biological …, 2020 - ASBMB

Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed to control
this current pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS …

Kaydet Alıntı yap Alıntılanma sayısı: 1057 İlgili makaleler 8 sürümün hepsi

[Free GPT-4]
[DeepSeek]

[PDF] cell.com Full View

Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice

AJ Pruijssers, AS George, A Schäfer, SR Leist… - Cell reports, 2020 - cell.com

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the novel viral disease COVID-19. With no approved therapies, this pandemic illustrates the …

Kaydet Alıntı yap Alıntılanma sayısı: 525 İlgili makaleler 19 sürümün hepsi

Uyarı oluştur

Alıntı yap

Gelişmiş arama

Kitaplığım'a kaydedildi

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Remdesivir against COVID-19 and other viral diseases

Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice